Chemotherapy of glioblastoma by targeted liposomal platinum compounds with focused ultrasound

Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS

Volumn , Issue , 2013, Pages 6289-6292

  Yang, Feng Yi ^a   Horng, Shih Cheng ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUMOR EFFECT; BIOPHOTONIC IMAGING; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CONJUGATED LIPOSOMES; FOCUSED ULTRASOUND; GLIOBLASTOMAS; TUMOR PROGRESSIONS;

CHEMOTHERAPY; DRUG DOSAGE; LIPOSOMES; PLATINUM COMPOUNDS; TUMORS; ULTRASONICS;

DIAGNOSIS;

ANTINEOPLASTIC AGENTS; AP1 PEPTIDE; CISPLATIN; LIPOPLATIN; LIPOSOMES; PEPTIDES;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHEMISTRY; COMBINED MODALITY THERAPY; GLIOBLASTOMA; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LUMINESCENT MEASUREMENTS; MALE; METABOLISM; MICE; MICE, INBRED NOD; MICE, SCID; PATHOLOGY; TRANSPLANTATION, HETEROLOGOUS;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL LINE, TUMOR; CISPLATIN; COMBINED MODALITY THERAPY; GLIOBLASTOMA; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LIPOSOMES; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PEPTIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84886493319     PISSN: 1557170X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/EMBC.2013.6610991     Document Type: Conference Paper

References (16)

1. L. Arko, et al., "Experimental approaches for the treatment of malignant gliomas, " Pharmacol Ther, vol. 128, pp. 1-36, Oct 2010.
2. A. Jemal, et al., "Cancer statistics, 2006, " CA Cancer J Clin, vol. 56, pp. 106-30, Mar-Apr 2006.
3. S. Sathornsumetee and J. N. Rich, "Designer therapies for glioblastoma multiforme, " Ann N Y Acad Sci, vol. 1142, pp. 108-32, Oct 2008.
4. M. Westphal, et al., "A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma, " Neuro Oncol, vol. 5, pp. 79-88, Apr 2003.
5. K. Hynynen, et al., "Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications, " Neuroimage, vol. 24, pp. 12-20, Jan 1 2005.
6. K. Hynynen, et al., "Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits, " Radiology, vol. 220, pp. 640-6, Sep 2001.
7. F. Y. Yang, et al., "Evaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasound, " Int J Nanomedicine, vol. 7, pp. 723-30, 2012.
8. F. Y. Yang, et al., "Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound, " J Nucl Med, vol. 52, pp. 478-84, Mar 2011.
9. F. Y. Yang, et al., "Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation, " J Control Release, vol. 150, pp. 111-6, Feb 28 2011.
10. F. Y. Yang, et al., "Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption, " J Acoust Soc Am, vol. 126, pp. 3344-9, Dec 2009.
11. C. M. Sorenson and A. Eastman, "Mechanism of cis- diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks, " Cancer Res, vol. 48, pp. 4484-8, Aug 15 1988.
12. D. R. Gandara, et al., "Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities, " J Clin Oncol, vol. 13, pp. 490-6, Feb 1995.
13. F. Y. Yang, et al., "Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound, " Int J Nanomedicine, vol. 7, pp. 965-74, 2012.
14. F. Y. Yang, et al., "Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme, " J Control Release, vol. 160, pp. 652-8, Jun 28 2012.
15. F. Y. Yang, et al., "Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound, " PLoS One, vol. 7, p. e45468, 2012.
16. W. H. Lee, et al., "Establishment and characterization of a malignant glioma cell line, GBM8401/TSGH, NDMC, " J Surg Oncol, vol. 38, pp. 173-81, Jul 1988.